These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3227403)

  • 1. Inhibition of tolbutamide metabolism by antimalarial drugs.
    Karbwang J; Back DJ; Bunnag D; Breckenridge AM
    Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):235-41. PubMed ID: 3227403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ethinyloestradiol and tolbutamide metabolism by quinoline derivatives in vitro.
    Riviere JH; Back DJ
    Chem Biol Interact; 1986 Oct; 59(3):301-8. PubMed ID: 3769058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of selected antimalarial drugs and inhibitors of cytochrome P-450 3A4 on halofantrine metabolism by human liver microsomes.
    Baune B; Furlan V; Taburet AM; Farinotti R
    Drug Metab Dispos; 1999 May; 27(5):565-8. PubMed ID: 10220483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition.
    Knodell RG; Hall SD; Wilkinson GR; Guengerich FP
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1112-9. PubMed ID: 3598900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysaccharide peptides from COV-1 strain of Coriolus versicolor inhibit tolbutamide 4-hydroxylation in the rat in vitro and in vivo.
    Yeung JH; Chan SL; Or PM
    Food Chem Toxicol; 2006 Aug; 44(8):1414-23. PubMed ID: 16698161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mefloquine on hepatic drug metabolism in the rat: comparative study with primaquine.
    Riviere JH; Back DJ
    Biochem Pharmacol; 1985 Feb; 34(4):567-71. PubMed ID: 3871613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily.
    Relling MV; Aoyama T; Gonzalez FJ; Meyer UA
    J Pharmacol Exp Ther; 1990 Jan; 252(1):442-7. PubMed ID: 2299601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
    Marathe PH; Shen DD; Nelson WL
    Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system.
    Palamanda J; Feng WW; Lin CC; Nomeir AA
    Drug Metab Dispos; 2000 Jan; 28(1):38-43. PubMed ID: 10611138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliclazide hydroxylation by rat liver microsomes.
    Rieutord A; Stupans I; Shenfield GM; Gross AS
    Xenobiotica; 1995 Dec; 25(12):1345-54. PubMed ID: 8719909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolbutamide 4-hydroxylase activity of human liver microsomes: effect of inhibitors.
    Purba HS; Back DJ; Orme ML
    Br J Clin Pharmacol; 1987 Aug; 24(2):230-4. PubMed ID: 3620298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
    Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
    Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of tolbutamide hydroxylation in rat liver microsomes by high-performance liquid chromatography: effect of psychoactive drugs on in vitro activity.
    Ho JW; Moody DE
    Life Sci; 1993; 52(1):21-8. PubMed ID: 8417276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.
    Back DJ; Tjia JF; Karbwang J; Colbert J
    Br J Clin Pharmacol; 1988 Jul; 26(1):23-9. PubMed ID: 3203057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations.
    Miners JO; Smith KJ; Robson RA; McManus ME; Veronese ME; Birkett DJ
    Biochem Pharmacol; 1988 Mar; 37(6):1137-44. PubMed ID: 3355588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.
    Ko JW; Sukhova N; Thacker D; Chen P; Flockhart DA
    Drug Metab Dispos; 1997 Jul; 25(7):853-62. PubMed ID: 9224780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro.
    Murray M; Butler AM; Stupans I
    J Pharmacol Exp Ther; 1994 Aug; 270(2):645-9. PubMed ID: 8071856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.
    Doecke CJ; Veronese ME; Pond SM; Miners JO; Birkett DJ; Sansom LN; McManus ME
    Br J Clin Pharmacol; 1991 Feb; 31(2):125-30. PubMed ID: 2049228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.